Prescription drug · BLA
Elzonris (Tagraxofusp) NDC 72187-0401
Tagraxofusp 1000 ug/mL · Injection, Solution · Intravenous · Stemline Therapeutics, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72187-0401-1 | 72187040101 | 1 VIAL, SINGLE-DOSE in 1 CARTON (72187-0401-1) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Jan 18, 2019 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Elzonris
- Generic name (nonproprietary)
- tagraxofusp
- Active ingredients
- Tagraxofusp — 1000 ug/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- Stemline Therapeutics, Inc.NDC labeler code 72187
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 761116
- Marketing start
- Listing expires
- Other FDA classes
- CD123 Interactions (Mechanism)Cytotoxins (Chemical structure)
- Identifiers
- Product ID 72187-0401_f219a6c1-2e94-40a7-8b66-28520f7bb7f7SPL ID f219a6c1-2e94-40a7-8b66-28520f7bb7f7SPL set ID 80eb1080-fe20-4af0-b2a5-a67999923fa8RxCUI 2109059, 2109064UNII 8ZHS5657EHUPC 0372187040118
- Pharmacologic class
- CD123 Interaction; Cytotoxin
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N472187040101followed by a unit qualifier and the quantityPackage 72187-0401-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
ELZONRIS is indicated for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years and older. ELZONRIS is a CD123-directed cytotoxin indicated for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years and older ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 72187-0401
- What is NDC 72187-0401?
- 72187-0401 is the product NDC for Elzonris (tagraxofusp), Tagraxofusp 1000 ug/mL injection, solution, listed with the FDA by Stemline Therapeutics, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Elzonris (Tagraxofusp).
- What is the active ingredient?
- Tagraxofusp.
- Who is the labeler?
- Stemline Therapeutics, Inc., NDC labeler code 72187. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Elzonris?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.